IL6 and glioblastoma: Quantification of IL-6 mRNA with qRT–PCR revealed a highly significant increase in the mean IL-6/ABL ratio in GBM (33.3%) as compared with non-GBM (1.5%; Kruskal–Wallis test, P=3.8 × 10−6).